Expert consensus on the management of systemic sclerosis-associated interstitial lung disease

BACKGROUND: Systemic sclerosis (SSc) is a rare, complex, connective tissue disorder. Interstitial lung disease (ILD) is common in SSc, occurring in 35–52% of patients and accounting for 20–40% of mortality. Evolution of therapeutic options has resulted in a lack of consensus on how to manage this co...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahaghi, Franck F., Hsu, Vivien M., Kaner, Robert J., Mayes, Maureen D., Rosas, Ivan O., Saggar, Rajan, Steen, Virginia D., Strek, Mary E., Bernstein, Elana J., Bhatt, Nitin, Castelino, Flavia V., Chung, Lorinda, Domsic, Robyn T., Flaherty, Kevin R., Gupta, Nishant, Kahaleh, Bashar, Martinez, Fernando J., Morrow, Lee E., Moua, Teng, Patel, Nina, Shlobin, Oksana A., Southern, Brian D., Volkmann, Elizabeth R., Khanna, Dinesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830797/
https://www.ncbi.nlm.nih.gov/pubmed/36624431
http://dx.doi.org/10.1186/s12931-022-02292-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830797/
https://www.ncbi.nlm.nih.gov/pubmed/36624431
http://dx.doi.org/10.1186/s12931-022-02292-3

Ejemplares similares